![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Private equity sponsors have enjoyed a strong deal environment during a period of sustained economic growth. But PE firms are now facing significant challenges. Sponsors remain under tremendous pressure to deploy capital against continuing high multiples and resulting high enterprise values. Amidst a continuing proliferation of investment dollars competing for fewer good deals, the PE industry and its portfolio companies must deal with rising inflation within a generally uncertain economy, increasing geopolitical tensions, renewed regulatory gauntlets, and swelling social impact pressures. Successful transactions will require that PE sponsors become nimble, move quickly, and readjust strategies.
Read the full Bloomberg Law article, "Private equity challenges necessitate reevaluating strategies."
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023